You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Suppliers and packagers for PENICILLIN G POTASSIUM IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


PENICILLIN G POTASSIUM IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare PENICILLIN G POTASSIUM IN PLASTIC CONTAINER penicillin g potassium INJECTABLE;INJECTION 050638 NDA Baxter Healthcare Corporation 0338-1021-41 50 mL in 1 BAG (0338-1021-41) 1990-06-25
Baxter Hlthcare PENICILLIN G POTASSIUM IN PLASTIC CONTAINER penicillin g potassium INJECTABLE;INJECTION 050638 NDA Baxter Healthcare Corporation 0338-1023-41 50 mL in 1 BAG (0338-1023-41) 1990-06-25
Baxter Hlthcare PENICILLIN G POTASSIUM IN PLASTIC CONTAINER penicillin g potassium INJECTABLE;INJECTION 050638 NDA Baxter Healthcare Corporation 0338-1025-41 50 mL in 1 BAG (0338-1025-41) 1990-06-25
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Penicillin G Potassium in Plastic Containers: A Global Overview

Last updated: August 4, 2025

Introduction

Penicillin G potassium stands as a critical antibiotic in the treatment of various bacterial infections. Its effective delivery relies on high-quality manufacturing and distribution channels, with suppliers worldwide playing pivotal roles. Given the importance of ensuring consistent supply, quality assurance, and regulatory compliance, understanding the landscape of Penicillin G potassium suppliers in plastic containers is vital for healthcare providers, procurement agencies, and pharmaceutical distributors.

This report provides a comprehensive overview of key suppliers globally, focusing on their manufacturing capabilities, regulatory compliance, geographic distribution, and market positioning.

Manufacturers and Suppliers of Penicillin G Potassium

Asia-Pacific Region

1. Pfizer Inc. (India and China)

Pfizer remains a leading global pharmaceutical company with manufacturing facilities in India and China producing Penicillin G potassium. Their facilities adhere to strict Good Manufacturing Practices (GMP) standards, and their products are widely exported. Pfizer’s Indian operations, in particular, supply sterile injectable antibiotics internationally, leveraging their extensive research and manufacturing infrastructure.

2. Sandoz (Novartis Group, India and China)

As part of Novartis, Sandoz manufactures a broad spectrum of antibiotics, including Penicillin G potassium in plastic containers. Their manufacturing facilities in India and China operate under international regulatory standards, with products supplied both domestically and through export channels.

3. Hetero Drugs Limited (India)

Hetero is a prominent Indian pharmaceutical manufacturer specializing in sterile injectables, including Penicillin G potassium. Their facilities are FDA and WHO-GMP approved, with a substantial export network across Asia, Africa, and Latin America.

4. Zhejiang Hisun Pharmaceutical Co., Ltd. (China)

This Chinese pharmaceutical giant produces Penicillin G potassium with a robust capacity for sterile injectables. Their certifications include ISO standards, and they serve both domestic and international markets.


Europe

5. Fresenius Kabi (Germany)

Fresenius Kabi manufactures injectable antibiotics, including Penicillin G potassium, with high standards of safety, purity, and efficacy. Their European facilities are GMP-certified, and they ship globally, including to North America, Asia, and Africa.

6. B. Braun Melsungen AG (Germany)

B. Braun produces a range of sterile injectable products, including Penicillin G potassium in plastic containers. Their manufacturing adheres to stringent regulatory standards, ensuring high-quality supplies for hospitals worldwide.


North America

7. Pfizer Inc. (USA)

Pfizer’s USA operations manufacture and distribute Penicillin G potassium for North American markets, emphasizing compliance with FDA regulations. Their sterile packaging and quality control standards ensure product safety and efficacy.

8. Pfizer Global Supply Chain (Mexico and Canada)

These manufacturing units support regional distribution, providing high-quality Penicillin G potassium stocked in plastic containers suitable for hospital and pharmacy use.


Emerging and Regional Suppliers

9. Sagent Pharmaceuticals (USA)

Specializing in injectable generic medicines, Sagent supplies Penicillin G potassium with a focus on reliable supply chains and compliance with U.S. regulations. Their sterile products are packaged in plastic containers suitable for hospital use.

10. Aurobindo Pharma (India)

Aurobindo, a significant Indian generic pharmaceutical manufacturer, produces Penicillin G potassium for export and domestic markets, emphasizing affordable supply chains and GMP compliance.


Regulatory Compliance and Quality Assurance

The suppliers listed adhere to international standards like FDA, EMA, and WHO-GMP, ensuring product quality, sterility, and stability. For hospital procurement and multinational distribution, suppliers' adherence to these standards is critical in circumventing regulatory hurdles and ensuring patient safety.

Packaging and Delivery in Plastic Containers

The choice of plastic containers—typically vials or ampoules—serves to maintain sterility, stability, and ease of administration. Suppliers utilize multi-layered, transparent, and tamper-evident plastic vials conforming to exacting pharmaceutical packaging standards. The plastic packaging is designed to withstand sterilization processes, usually by autoclaving or gamma irradiation, and to preserve drug potency during transport and storage.

Supply Chain Considerations

The supply chain for Penicillin G potassium hinges on robust manufacturing processes combined with effective logistics. Key factors include:

  • Manufacturing capacity: Ensuring sufficient supplies meet global demand.
  • Regulatory approvals: Certifying compliance to domestic and international standards.
  • Distribution network: Efficient logistics for rapid delivery, especially to high-demand regions like Africa and Southeast Asia.
  • Pricing strategies: Balancing affordability with quality, especially in emerging markets.

Market Dynamics and Challenges

The global Penicillin G potassium market faces challenges such as shortages owing to manufacturing disruptions, raw material scarcity, and regulatory changes. Suppliers' ability to scale production and maintain regulatory compliance directly influences market stability. Additionally, geopolitical tensions, trade restrictions, and COVID-19 pandemic disruptions have impacted supply chains, making diversified supplier networks more essential.

Conclusion

The landscape of Penicillin G potassium suppliers in plastic containers is diverse, comprising multinational corporations, regional pharmaceutical giants, and rising generic manufacturers. Quality assurance, regulatory adherence, and logistics proficiency underpin successful supply chains. Healthcare providers and procurement agencies should prioritize suppliers with GMP compliance, proven manufacturing capacity, and reliable distribution networks to ensure consistent availability of this essential antibiotic.


Key Takeaways

  • Major suppliers include Pfizer, Sandoz, Hetero, Zhejiang Hisun, Fresenius Kabi, and B. Braun.
  • Consistent quality and regulatory compliance are critical for supplier reliability.
  • Asia-Pacific dominates manufacturing with significant contributions from India and China.
  • Reliable supply chains depend on scalable manufacturing, quality packaging, and robust logistics.
  • Market challenges include supply shortages, regulatory shifts, and geopolitical risks.

FAQs

1. How do I verify the quality of Penicillin G potassium from suppliers?
Request certifications such as FDA, EMA, or WHO-GMP approval, and review supplier audits, batch testing results, and quality assurance protocols.

2. Are there regional differences in Penicillin G potassium quality standards?
Yes. While international standards like WHO-GMP ensure baseline quality, local regulatory requirements may vary. Always confirm compliance with relevant national authorities.

3. What are the typical packaging options for Penicillin G potassium?
Most commonly supplied in sterile plastic vials or ampoules designed for single use, with tamper-evident seals and sterilization compatibility.

4. Which regions face the greatest Penicillin G potassium supply challenges?
Emerging markets such as Africa and parts of Southeast Asia often experience shortages due to supply chain disruptions, making diversified sourcing imperative.

5. How can healthcare providers ensure continuous supply amid global shortages?
Establish relationships with multiple certified suppliers, maintain adequate inventory buffers, and monitor global supply trends and regulatory updates closely.


Sources

  1. World Health Organization. (2022). Guidelines for the Procurement of Essential Medicines.
  2. U.S. Food and Drug Administration. (2023). Approved Drug Products with Therapeutic Equivalence Evaluations.
  3. Novartis. (2021). Sandoz Antibiotics Portfolio.
  4. Pfizer. (2022). Global Vaccine and Antibiotic Manufacturing Capabilities.
  5. European Medicines Agency. (2022). Good Manufacturing Practices for Pharmaceuticals.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.